Multimedia
Featured Video
Discover NIMH: Drug Discovery and Development
One of the most exciting recent breakthroughs from research funded by the National Institute of Mental Health (NIMH) is the development of a fast-acting medication for treatment-resistant depression based on ketamine. This treatment is bringing new hope to people and families affected by major depression.
Health Topics
-
Director’s Innovation Speaker Series: The Opioid Crisis: Disrupting the Status Quo with the HEALing Communities Study
-
Director’s Innovation Speaker Series: Ecological Grief and Anxiety: A Healthy Response to Climate Change
-
Director’s Innovation Speaker Series: HIV-1 and SARS-CoV-2 Effects on Brain and Mind Health: A Tale of Two Viruses
-
Center for Global Mental Health Research Webinar Series: Writing a Successful Individual Training Grant Application Focused on Global Mental Health
Populations
-
Health Economics at NIMH and NIDA – Domestic and International
-
Director’s Innovation Speaker Series: Ecological Grief and Anxiety: A Healthy Response to Climate Change
-
Director’s Innovation Speaker Series: Transformative Research Requires Insider Researchers
-
Center for Global Mental Health Research Webinar Series: Grants Management: Post Award
Research
-
Director’s Innovation Speaker Series: The Opioid Crisis: Disrupting the Status Quo with the HEALing Communities Study
-
Health Economics at NIMH and NIDA – Domestic and International
-
Director’s Innovation Speaker Series: Transformative Research Requires Insider Researchers
-
Center for Global Mental Health Research Webinar Series: Grants Management: Post Award